You are here

IMMUTEP

ASCO Preview: Immutep, InxMed and Faron Release New Clinical Findings

BioSpace

Tue, 05/31/22 - 10:49 am

non-small cell lung cancer

Faron Pharmaceuticals

After seeing its GSK-backed trial ditched, LAG-3-focused Immutep secures cash, plots new trial push

Fierce Biotech

Mon, 06/21/21 - 11:06 am

Second-quarter catalysts for the smaller players

EP Vantage

Wed, 04/7/21 - 10:25 am

Fulcrum Therapeutics

Gemini Therapeutics

GlaxoSmithKline's Immutep-partnered midstage GI med culled in ulcerative colitis

Fierce Biotech

Fri, 01/22/21 - 10:37 am

ulcerative colitis

The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings

Yahoo/Benzinga

Mon, 10/14/19 - 09:43 am

Flexion Therapeutics

Clearside Biomedical

Assertio Therapeutics

Aldeyra Therapeutics

Lineage Therapeutics